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A B S T R A C T   
High body mass index (BMI) is known to be associated with elevated blood pressure (BP). The present study aims 
to determine the relative importance of the two components of BMI, fat mass and lean body mass index, on BP 
levels. 
We assessed body composition with bioimpedance and performed 24 hour ambulatory BP measurements in 
534 individuals (mean age 61 ± 3 years) who had no cardiovascular medication. Fat mass index and lean mass 
index were calculated analogously to BMI as fat mass or lean body mass (kg) divided by the square of height 
(m2). 
Both fat mass index and lean mass index showed a positive, small to moderate relationship with all 24 hour BP 
components independently of age, sex, smoking, and leisure-time physical activity. There were no interaction 
effects between fat mass index and lean mass index on the mean BP levels. 
Adult lean body mass is a significant determinant of BP levels with an equal, albeit small to moderate 
magnitude as fat mass. Relatively high amount of muscle mass may not be beneficial to cardiovascular health.   
Introduction 
The positive relationship of body mass index (BMI) with blood 
pressure (BP) has been demonstrated in several large-scale observational 
studies [1–8]. Importantly, a causal association between BMI and hy-
pertension has recently been verified by two Mendelian randomization 
studies [9,10]. 
Because BMI is a ratio of the total body mass (weight) and the square 
of height, BMI cannot discriminate fat mass from lean body mass of a 
person. This issue was considered among the UK Biobank participants, in 
whom genetically predicted fat mass index (calculated analogously to 
BMI as fat mass divided by height squared) was associated with hyper-
tension, the odds ratio (OR) for hypertension being 1.12 (95% CI 1.04 to 
1.20) per genetically predicted 1 kg/m2 increase of fat mass index [10]. 
However, the causal association between higher genetically predicted 
fat-free mass index and hypertension did not quite reach statistical sig-
nificance: OR 1.08 (95% CI 0.99 to 1.19) [10]. This information implies 
that genetic variants of fat mass influence BP levels across life course, 
but the role of fat-free mass is unclear. The factors that trigger disease 
may not be the same as those that influence it́s progression [11]. Even 
though genetic variation in fat-free mass may not trigger elevated BP, it 
is possible that fat-free mass gained during life course may have an 
impact on BP levels in adulthood. 
We had the opportunity to assess body composition and 24 hour 
ambulatory BP measurements (AMBP) in 534 adult individuals who had 
no medication affecting vasculature. To determine the relative impor-
tance of fat mass and fat-free mass on BP levels, we divided BMI into it́s 
two components, fat mass index (FMI) and lean mass index (LMI). We 
hypothesized that LMI also plays a role in BP regulation. 
Materials and methods 
The Helsinki Birth Cohort Study (HBCS) includes 8760 men and 
women who were born at Helsinki University Central Hospital between 
the years 1934 and 1944. For the clinical study, random-number tables 
were used to select a subset of people from the initial epidemiological 
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study cohort who were still alive and living in Finland in 1971. In order 
to achieve a sample size in excess of 2000 people, 2902 persons were 
invited, and 2003 of them visited the clinic in the years 2001-2004. The 
procedures used at the clinic visit have been described in greater detail 
previously [12]. Briefly, the subjects attended the clinic after an over-
night fast. Height and weight were measured in light indoor clothing and 
without shoes. Height was measured to the nearest 0.1 cm, and weight to 
the nearest 0.1 kg. Body composition was assessed by bio-impedance, 
using an eight-polar tactile electrode system (InBody 3.0, Biospace Co, 
Ltd, Seoul, Korea). Between-day precision of InBody 3.0 has been re-
ported to be 2.7% in a sample of individuals with a mean age of 53 years 
[13]. BMI, LMI and FMI were calculated as weight, lean body mass and 
fat mass (kg) divided by the square of height (m2), respectively. Fat and 
lean mass indices were divided according to median values, and four 
body composition categories were created: 1) low FMI and low LMI, 2) 
low FMI and high LMI, 3) high FMI and low LMI, 4) high FMI and high 
LMI. 
For 24 h AMBP, oscillometric Spacelabs 90207 monitors (Spacelabs 
Healthcare, Issaquah, Washington, USA) were used with cuffs of 
appropriate size applied to the non-dominant arm. The measurement 
protocol for each subject included a reading once in every 30 min, 
except from 10 PM to 7 AM, when it included one reading in every hour. 
We aimed at a number of readings that meets recommendations [14] but 
allows maximal compliance. Pulse pressure (PP) was defined as the 
difference between systolic and diastolic BP. Mean arterial pressure 
(MAP) was calculated as DBP + (SBP – DBP)/3. Office BP was measured 
from the right arm while the subject was in the sitting position, and it 
was recorded as the mean of two successive readings from a mercury 
sphygmomanometer. 
Leisure-time physical activity (LTPA) was assessed with the vali-
dated 12-month Kuopio Ischemic Heart Disease questionnaire [15]. In-
formation on type, mean duration per month and mean 
frequency/month of LTPA was collected. We defined a specific meta-
bolic equivalent of task (MET, 1 MET = 3.5 ml of O2/kg-1/min-1 or 1 
kcal/kg-1/h-1) for each reported activity (n = 47) to determine the ab-
solute intensity of the activities. LTPA was reported as a time-weighted 
average intensity (TWA-MET) as previously reported [16]. 
Years of education, smoking status, and current medication were 
assessed by questionnaires. 
For the present analysis, we selected only subjects (n = 534) who had 
no cardiovascular medication. 
Blood samples were drawn after overnight fasting and were stored at 
- 70 ◦C prior to analysis. High sensitivity CRP (hs-CRP) was analyzed 
with immunoturbidimetric method using Konelab T-serie High 
Sensitivity-CRP analyzer (Thermo Fisher Scientific Oy, Vantaa, Finland). 
Interleukin-6 (IL-6) and tumor-necrosis factor-α (TNF-α) were analyzed 
with multiplex sandwich immunoassays. The highest between-run 
variation was 13% for both IL-6 and TNF-α. The amount of samples 
with concentrations below or above the measurement range of the 
analysis method were 4% for TNF-α, 5% for hs-CRP, and 50% for IL-6. 
Ethical approval 
Written informed consent was obtained from each subject before any 
procedures were carried out. The Ethics Committee for Epidemiology of 
Helsinki and Uusimaa Hospital District approved the study. The study 
met the institution’s or the data curator’s guidelines for protection of 
human subjects concerning their safety and privacy. 
Statistical analysis 
The descriptive statistics were presented as means with SDs or as 
counts with percentages. The relationship between FMI and LMI was 
modeled using linear regression analysis. Results were analysed using 
factorial (two between-subjects factors: FMI and LMI) analysis of vari-
ance (ANOVA) and logistic models. Models included main effects of FMI 
and LMI and their interaction. Models regarding BP values included age, 
sex, smoking, and LTPA as covariates. A bootstrap method was used 
when the theoretical distribution of the test statistics was unknown or in 
the case of a violation of the assumptions. Multivariate linear regression 
analysis was used to identify the relationship between FMI and LMI as 
continuous variables and the ambulatory BP components with stan-
dardized regression coefficient Beta (β). The Beta value is a measure of 
how strongly the predictor variable (FMI or LMI) influences the criterion 
(BP) variable. The Beta is measured in units of SD. Cohen’s standard for 
Beta values above 0.10, 0.30 and 0.50 represents small, moderate and 
large relationships, respectively. Because both IL-6 and TNF-α values 
were extremely right-skewed (not normally distributed), they were 
transformed to normality using a van der Waerden’s rank-based 
normalization methods [17]. Unadjusted and adjusted (partial) corre-
lations between office and 24 h AMBP values and components of BMI 
were calculated by the Pearson method. Otherwise, correlation co-
efficients with 95% CI were calculated by the Spearman method. The 
normality of variables was evaluated using the Shapiro–Wilk W test. 
Stata 16.0 (StataCorp LP; College Station, Texas, USA) statistical pack-
age was used for the analysis. 
Results 
We assessed body composition and cardiometabolic risk factors 
including 24-hour AMBP in 534 individuals with mean age of 61 (SD 3) 
years, 50.4% being females. None of the subjects had any cardiovascular 
medication. 
The relation of FMI to LMI was linear in both sexes. Correlation of 
FMI with LMI was r = 0.51 (95% CI: 0.41 to 0.59) in men and r = 0.63 
(95% CI: 0.55 to 0.70) in women. The subjects were categorized ac-
cording to medians of FMI and LMI as having ĺow FMI and low LMÍ, ĺow 
FMI and high LMÍ, ́high FMI and low LMÍ, and ́high FMI and high LMÍ. 
(Fig. 1) 
Table 1 displays the baseline characteristics of the subjects according 
to categorization as having low or high FMI or LMI, respectively. Persons 
with low FMI and high LMI were mostly men whereas persons with high 
FMI and low LMI were mostly women. Both components of BMI showed 
a positive association with waist circumference and plasma triglyceride 
level. FMI also showed a positive association with overall body fat 
percentage, total cholesterol level, and hs-CRP level. FMI showed a 
Fig. 1. The relationship between fat mass index and lean mass index in men 
and women. The solid lines show estimated linear regression with 95% confi-
dence intervals. The dashed lines indicate the medians of lean mass index (LMI) 
and fat mass index (FMI). 
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negative relationship with years of education, HDL cholesterol level 
among males, LTPA, and IL-6 concentration. LMI was negatively asso-
ciated with body fat percentage and total cholesterol level, whereas the 
association was positive with plasma glucose concentration and LTPA. 
Office measured BP components, with the exception of PP, showed a 
positive relationship with both FMI and LMI. The interaction between 
FMI and LMI was significant only for BMI and waist circumference 
among women. 
Spearmańs correlation coefficient showed only a weak positive cor-
relation between LMI and hs-CRP level [r = 0.15 (95% CI: 0.06 to 0.23)], 
but there was no association between LMI and TNF-α [r = -0.02 (95% CI: 
-0.11 to 0.06)] or IL-6 [r = -0.04 (95% CI: -0.12 to 0.05)] levels. 
When adjusted for age, sex, smoking, and LTPA, both FMI and LMI 
showed a positive association with daytime and 24 h mean BP variables 
except PP values. Only FMI had a main effect on night-time BP values. 
There were no interaction effects between FMI and LMI on the mean 
AMBP levels. (Table 2) 
Table 3 shows correlation coefficients between the office BP and 24 h 
AMBP values and components of BMI. There was a statistical difference 
between unadjusted and adjusted (age, sex, smoking, and LTPA) office 
DBP and 24 h DBP regarding FMI. 
In multiple regression analysis, both FMI and LMI showed a positive 
small-moderate relationship with all 24 h AMBP components indepen-
dently of age, sex, smoking, and LTPA. (Fig. 2). 
Discussion 
The novel finding of this study is that adult lean body mass is a 
significant determinant of BP levels with an equal, albeit small to 
moderate magnitude as fat mass. The relationship between BP and lean 
body mass is positive irrespective of age, sex, smoking, and LTPA. 
Given that muscle mass is the major constituent of lean body mass, it 
is probable that high muscle mass explains the positive relationship 
between high LMI and BP levels. Generally, muscle mass has been 
considered beneficial to health, and it is not known whether there is a 
threshold value above which muscle mass is no more advantageous. 
Skeletal muscle cells produce and secrete cytokines called myokines. 
Chronically increased systemic concentrations of myokines IL-1β, IL-6, 
IL-8, IL-10, and TNF-α have been linked to the development of many 
diseases associated with inflammation and endothelial dysfunction [18]. 
We hypothesized that these myokines could mediate the effect of muscle 
mass on blood pressure. However, we found no evidence for this since 
LMI was not associated with IL-6, TNF-α or hs-CRP. It should be noted 
that IL-6 is produced and secreted only when muscle fibres contract, but 
TNF-α only after extremely high-intensity physical activity [19]. The 
laboratory tests in our study were collected in the morning before any 
strenuous activities, which might explain the lack of associations. 
Interestingly, the positive relationship between LMI and AMBP levels at 
daytime was not observed during night-time BP measurements. Thus, it 
may be possible that the elevated muscle mass per se does not raise BP 
levels, but muscle contraction and subsequent myokine release at day-
time is sufficient to raise also 24 h AMBP levels. The role of muscle mass 
in BP regulation has recently been suggested in a Mendelian randomi-
zation analyses in which BMI, but not central adiposity, was causally 
associated with higher IL-6 and also ECG measures indexing left ven-
tricular hypertrophy [9]. 
The relationship of both LMI and FMI with all 24 h AMBP compo-
nents was independent of current LTPA, but it is possible that the as-
sociations could be explained by the participantś earlier LTPA. Laine 
et al. have shown that Finnish male former elite athletes in endurance 
sports (long- and middle-distance running, cross country skiing) had 
lower risk for hypertension than their matched controls in later life even 
after adjustment for present LTPA [20]. This favorable effect was not 
detected in groups of former athletes engaged in mixed sports (soccer, 
ice hockey, basketball, track and field: jumpers, sprinters, hurdles, de-
cathletes) and power sports (boxing, wrestling, weight lifting, track and 
field throwers) which typically involve intensive resistance training 
[20]. Thus, it is reasonable to assume that resistance training in order to 
raise muscle mass is not advisable to BP control. In this regard, the 
current European recommendation for moderate-intensity resistance 
Table 1 
Characteristics of the subjects according to fat mass index (FMI) and lean mass index (LMI). Values are means (standard deviations) or numbers (percentages).   
FMI low FMI high P-value      
Main effect Interaction  
LMI lowN=112 LMI highN=155 LMI lowN=155 LMI highN=112 FMI LMI  
Women, n (%) 69 (62) 6 (4) 151 (97) 48 (43) <0.001 <0.001 0.74 
Age, mean (SD) 61 (3) 61 (3) 61 (3) 61 (3) 0.10 0.22 0.63 
Education years, mean (SD) 12.5 (3.8) 12.8 (3.8) 11.6 (3.4) 11.4 (3.5) <0.001 0.93 0.32 
BMI (kg/m2), mean (SD) 22.5 (1.7) 26.3 (1.8) 27.1 (2.5) 31.8 (3.4) <0.001 <0.001 0.037 
WC (cm), mean (SD)        
Men 88 (7) 97 (6) 102 (5) 110 (9) <0.001 <0.001 0.65 
Women 77 (6) 83 (4) 89 (8) 103 (8) <0.001 <0.001 0.026 
Body fat-%, mean (SD) 23 (5) 21 (3) 35 (4) 34 (6) <0.001 <0.001 0.17 
Fasting glucose (mmol/l), mean (SD) 5.4 (0.7) 5.9 (1.3) 5.4 (0.8) 6.0 (1.2) 0.36 <0.001 0.68 
TC (mmol/l), mean (SD) 6.0 (1.0) 5.9 (1.0) 6.3 (1.0) 6.1 (1.1) 0.003 0.047 0.34 
HDL-C (mmol/l), mean (SD)        
Men 1.70 (0.49) 1.50 (0.40) 1.48 (0.31) 1.37 (0.33) 0.045 0.083 0.61 
Women 1.93 (0.43) 2.03 (0.71) 1.78 (0.45) 1.62 (0.36) 0.070 0.84 0.39 
Triglycerides (mmol/l), mean (SD) 1.16 (0.67) 1.37 (0.71) 1.42 (0.72) 1.72 (0.96) <0.001 <0.001 0.50 
Office BP (mmHg), mean (SD)        
SBP 139 (22) 145 (18) 146 (20) 151 (18) <0.001 <0.001 0.78 
DBP 84 (10) 90 (10) 88 (10) 93 (9) <0.001 <0.001 0.42 
PP 55 (16) 55 (13) 58 (16) 58 (15) 0.019 0.72 0.86 
MAP 103 (13) 109 (11) 108 (12) 112 (10) <0.001 <0.001 0.55 
Current smoker, n (%) 29 (26) 34 (22) 29 (19) 19 (17) 0.091 0.44 0.82 
LTPA, TWA-MET, mean (SD) 4.7 (1.3) 4.9 (1.1) 4.3 (0.8) 4.5 (1.3) <0.001 0.036 0.59 
hs-CRP (mg/l), mean (SD) 2.7 (6.5) 2.4 (5.0) 4.0 (6.6) 3.4 (3.4) <0.001 0.085 0.49 
TNF-α (pg/ml), median (IQR) 7.5 (5.3, 12.6) 7.9 (4.6, 11.8) 7.4 (5.3, 9.9) 7.4 (5.2, 10.0) 0.11 0.81 0.74 
IL-6 (pg/ml), median (IQR) 18 (6, 113) 25 (6, 131) 15 (4, 102) 10 (4, 88) 0.047 0.86 0.71 
Abbreviations: FMI, fat mass index; LMI, lean body index; BMI, body mass index; WC, waist circumference; TC, total cholesterol; HDL-C, high-density lipoprotein 
cholesterol; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; MAP, mean arterial pressure; LTPA, leisure-time 
physical activity; TWA-MET, time-weighted average intensity metabolic equivalent; hs-CRP, high-sensitivity C-reactive protein; TNF-α, tumor-necrosis factor-α; 
IQR, interquartile range; IL-6, interleukin-6. 
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training as an adjunct to aerobic exercise seems to be appropriate [21]. 
Recently, a report from the Health Professionals Follow-up Study 
utilized estimates of body fat mass and muscle mass derived from vali-
dated anthropometric prediction equations [22]. Compared with men in 
the lowest fifth of predicted fat or lean body mass, those in the highest 
fifth had hazard ratios of 1.67 (95 % CI 1.47 to 1.89) or 1.11 (95 % CI 
0.99 to 1.24) for cardiovascular death, respectively [22]. Although the 
association of predicted lean body mass and mortality from cardiovas-
cular disease did not quite reach statistical significance (P value for 
trend 0.10) [22], the results give support to our finding that high muscle 
mass may not be beneficial to cardiovascular health. It must also be 
noted that, although difficult to prove definitely, the relationship be-
tween fat mass and lean mass may partly be a result of the extra load 
caused by excess fat mass. This load serves as a long-term training 
stimulus leading to higher muscle mass and strength [23]. 
There is also evidence that lipid depots within muscle cells (intra-
myocellular lipid, IMCL) are associated with risk of arterial stiffness and 
may thus be a risk factor for elevated BP [24]. Identification of IMCL 
droplets is possible with proton magnetic resonance spectroscopy but 
not with the bioimpedance method used in our study. 
It appears unlikely that the other components of lean body mass, i.e. 
bones and organs, might contribute to the association of BP and LMI. Of 
note, the magnitude of the effect of both LMI and FMI on BP levels was 
only small to moderate in our study. According to the Poiseuillés law, 
the diameter of an artery plays by far the greatest role of all factors 
determining the rate of blood flow through a vessel [25]. Thus, body 
dimensions rather than body mass components, may have the major 
impact on BP levels. Indeed, we have shown in this study population that 
the relationship between BP and height is independent of BMI up to a 
BMI level of 27–28 kg/m2 [26]. BMI diminishes the impact of height on 
body size by dividing body mass by the square of height. Another 
important limitation of BMI is that persons with high lean body mass and 
low body fat mass – who are mostly men – may be regarded as over-
weight or obese without an excess of body fat mass. Our results suggest 
that in persons without cardiovascular disease needing medication, 
body mass is not a major determinant of BP level. 
This study is cross-sectional, which prevents us to define any causal 
relationships between LMI or FMI and BP levels. There is the potential 
for instrument bias in the bioimpedance analyses for FMI and LMI. 
However, the multifrequency bioimpedance technology used in our 
study with palm and sole electrodes has been shown to be sufficiently 
accurate at the group level also in the age group of our study participants 
[27]. The age range of our study participants was 57–70 years, which 
limits the generalization of the results to other age groups. However, by 
using AMBP we were able to measure circadian BP levels, and by 
excluding patients with vasoactive medications we could observe 
exclusively the relation between BP and body composition. 
Table 2 
Ambulatory blood pressure and heart rate according to fat mass index (FMI) and 
lean mass index (LMI). Adjusted for age, sex, smoking, and leisure-time physical 
activity. Values are means (standard deviations).   
FMI low FMI high P-value     
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<0.001 0.48 0.004 
Abbreviations: FMI, fat mass index; LMI, lean mass index; SBP, systolic blood 
pressure; DBP, diastolic blood pressure; PP, pulse pressure; 
MAP, mean arterial pressure 
Table 3 
Unadjusted and adjusted correlations (Pearson) between office and 24-hour 
blood pressure values and components of body mass index. Adjusted for age, 
sex, smoking, and leisure-time physical activity.   
Systolic BP Diastolic BP  
Office 24 h Office 24 h 
FMI     
Crude 0.19 (0.11 to 
0.27) 
0.10 (0.02 to 
0.19) 
0.14 (0.05 to 
0.22) 
-0.06 (-0.14 to 
0.03)*** 
Adjusted 0.22 (0.14 to 
0.30) 
0.19 (0.09 to 
0.28) 
0.24 (0.16 to 
0.31) 
0.10 (0.02 to 
0.18)*** 
LMI     
Crude 0.16 (0.07 to 
0.24) 
0.15 (0.06 to 
0.23) 
0.15 (0.07 to 
0.23) 
0.10 (0.02 to 
0.19) 
Adjusted 0.17 (0.09 to 
0.26) 
0.15 (0.07 to 
0.24) 
0.16 (0.07 to 
0.24) 
0.10 (0.02 to 
0.18) 
Statistical significance calculated using Sidak-adjusted probabilities *p<0.05, 
**p<0.01, 
*** p<0.001Abbreviations: BP, blood pressure; FMI, fat mass index; LMI, lean 
mass index 
Fig. 2. Magnitude of the simultaneous effect of lean mass index (LMI) and fat 
mass index (FMI) as continuous variables on the ambulatory blood pressure 
components. Beta (β) values with 95% confidence intervals were adjusted for 
age, sex, smoking, and leisure-time physical activity. 
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, 
pulse pressure; MAP, mean arterial pressure 
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Conclusions 
Both components of BMI, i.e. lean body mass and fat mass, have a 
positive but only small to moderate association with daytime and 24 h 
AMBP components. Relatively high muscle mass may not be beneficial 
to BP regulation. The current European recommendation for moderate- 
intensity resistance training as an adjunct to aerobic exercise seems to be 
appropriate [21]. 
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